B-Myb: a key regulator of the cell cycle.

作者: Mark K. Saville , Roger J. Watson

DOI: 10.1016/S0065-230X(08)60701-0

关键词:

摘要: Publisher Summary The chapter describes that B-Myb gene is subjected to two putative cyclin-dependent regulatory mechanisms during the cell cycle upregulation of mRNA abundance by derepression E2F/DRS-regulated transcription at G1/S boundary, and phosphorylation protein S phase. This dual mechanism has several features. First, it ensures in quiescent cells, there effectively no active because greatly down regulated little may be produced not activated kinases (Cdk)-mediated phosphorylation. Second, allows for a huge increase as cells go from G1 phase into Third, cycling partially inactivated dephosphorylation later stages only hyperactivated again on entry subsequent precise role B-myb regulation still unknown. transcriptional activator foreseen have function other genes whose products are involved synthesis components nucleotide biosynthesis DNA replication. As repressor, considered extinguishing expression negative regulators proliferation. BMyb potential activate promoters lack Myb binding site (MBS), these cannot predicted database searches. realization subject controls both its activity, this directs maximal activity phase, appears necessary proliferation leads conclude plays central downstream cyclins controlling basic coordinate passage through cycle.

参考文章(118)
Ullrich Sj, Mercer We, Amin M, Sauve Gj, Appella E, Romano Jw, Wild type human p53 is antiproliferative in SV40-transformed hamster cells. Oncogene. ,vol. 5, pp. 973- ,(1990)
J. Zwicker, F. C. Lucibello, L. A. Wolfraim, C. Gross, M. Truss, K. Engeland, R. Müller, Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. The EMBO Journal. ,vol. 14, pp. 4514- 4522 ,(1995) , 10.1002/J.1460-2075.1995.TB00130.X
K. Trauth, B. Mutschler, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, K.H. Klempnauer, Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes The EMBO Journal. ,vol. 13, pp. 5994- 6005 ,(1994) , 10.1002/J.1460-2075.1994.TB06945.X
F Kalkbrenner, K Moelling, S Guehmann, Transcriptional activation by human c-myb and v-myb genes. Oncogene. ,vol. 5, pp. 657- 661 ,(1990)
Noben-Trauth K, Klempnauer Kh, Kamano H, Sitzmann J, Expression of B-Myb during mouse embryogenesis. Oncogene. ,vol. 12, pp. 1889- 1894 ,(1996)
E.W. Lam, J.D. Morris, R. Davies, T. Crook, R.J. Watson, K.H. Vousden, HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. The EMBO Journal. ,vol. 13, pp. 871- 878 ,(1994) , 10.1002/J.1460-2075.1994.TB06330.X
K.M. Howe, C.F. Reakes, R.J. Watson, Characterization of the sequence-specific interaction of mouse c-myb protein with DNA. The EMBO Journal. ,vol. 9, pp. 161- 169 ,(1990) , 10.1002/J.1460-2075.1990.TB08092.X
Mark D. Carr, Ute Wollborn, Pauline B. McIntosh, Tom A. Frenkiel, John E. McCormick, Christopher J. Bauer, Karl-Heinz Klempnauer, James Feeney, Structure of the B-Myb DNA-binding domain in solution and evidence for multiple conformations in the region of repeat-2 involved in DNA binding: implications for sequence-specific DNA binding by Myb proteins. web science. ,vol. 235, pp. 721- 735 ,(1996) , 10.1111/J.1432-1033.1996.00721.X